Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PPD to support Merck & Co's vaccine development

This article was originally published in Scrip

Executive Summary

The CRO, PPD, is to support Merck & Co's vaccine portfolio with assay development and immunogenicity testing services over the next five years. PPD has bought Merck's 130,000sq ft vaccine testing laboratory and related equipment in Wayne, Pennsylvania, for an undisclosed sum and has hired almost 80 Merck professionals to run the facility. PPD plans to develop new technologies and assays to expand its immunochemistry and oncology vaccine testing services and biologics lab services for other clients. It will also provide traditional central laboratory and sample storage services to Merck for its clinical development activities for five years. The transaction closed at the end of last month.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts